Fundraising Fox

Max Kanevsky

Investor

Venture Partner at Excelerate Health Ventures

Greater Philadelphia

About

Former CTO at Certara and founder & CEO of Pinnacle 21, a clinical trial data validation standard acquired by Certara.

Experience

  1. Excelerate Health VenturesVenture Partnercurrent2025 β€” present
  2. CertaraAdvisor2024 β€” 2025
  3. CertaraChief Technology Officer2021 β€” 2024Radnor, Pennsylvania, United States
  4. Pinnacle 21 by CertaraFounder/CEO2011 β€” 2021Blue Bell, Pennsylvania, United States
  5. OpenCDISCFounder2008 β€” 2021
  6. IndependentConsultant2005 β€” 2011
  7. Regeneron PharmaceuticalsConsultant2008
  8. Merck & Co., IncClinical Data Exchange Specialist1999 β€” 2005

Skills & more

Clinical Trials41Lifesciences4Validation12CDISC17Clinical Research10Clinical Development18Data Management26Biotechnology11Oncology8SDLC2FDA5GCP13
+10 moreLife SciencesCDISC StandardsSoftware Development Life Cycle (SDLC)U.S. Food and Drug Administration (FDA)CRO ManagementGood Clinical Practice (GCP)SASPharmaceutical IndustryCROSQL

From Max's professional profile.

Colleagues at Excelerate Health Ventures

Frequently asked questions

Who is Max Kanevsky?
Former CTO at Certara and founder & CEO of Pinnacle 21, a clinical trial data validation standard acquired by Certara.
Where does Max Kanevsky work?
Max Kanevsky is Venture Partner at Excelerate Health Ventures.
Where did Max Kanevsky go to school?
Max Kanevsky studied at University of the Sciences in Philadelphia (BS, Biochemistry); Drexel University (MS, Software Engineering).

Same school

Shared employers